Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Jan 20;469(7330):362-7.
doi: 10.1038/nature09733.

Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells

Faiyaz Notta  1 , Charles G Mullighan, Jean C Y Wang, Armando Poeppl, Sergei Doulatov, Letha A Phillips, Jing Ma, Mark D Minden, James R Downing, John E Dick
Affiliations

Evolution of human BCR-ABL1 lymphoblastic leukaemia-initiating cells

Faiyaz Notta et al. Nature. .

Erratum in

  • Nature. 2011 Mar 10;471(7337):254

Abstract

Many tumours are composed of genetically diverse cells; however, little is known about how diversity evolves or the impact that diversity has on functional properties. Here, using xenografting and DNA copy number alteration (CNA) profiling of human BCR-ABL1 lymphoblastic leukaemia, we demonstrate that genetic diversity occurs in functionally defined leukaemia-initiating cells and that many diagnostic patient samples contain multiple genetically distinct leukaemia-initiating cell subclones. Reconstructing the subclonal genetic ancestry of several samples by CNA profiling demonstrated a branching multi-clonal evolution model of leukaemogenesis, rather than linear succession. For some patient samples, the predominant diagnostic clone repopulated xenografts, whereas in others it was outcompeted by minor subclones. Reconstitution with the predominant diagnosis clone was associated with more aggressive growth properties in xenografts, deletion of CDKN2A and CDKN2B, and a trend towards poorer patient outcome. Our findings link clonal diversity with leukaemia-initiating-cell function and underscore the importance of developing therapies that eradicate all intratumoral subclones.

PubMed Disclaimer

Comment in

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Nature. 2010 Oct 28;467(7319):1109-13 - PubMed
    1. Nature. 2008 May 1;453(7191):110-4 - PubMed
    1. Biochim Biophys Acta. 2010 Jan;1805(1):105-17 - PubMed
    1. Bioinformatics. 2009 Feb 1;25(3):315-21 - PubMed
    1. Clin Cancer Res. 2004 Aug 15;10(16):5355-60 - PubMed

Publication types

MeSH terms

Substances